This shows you the differences between two versions of the page.
Both sides previous revisionPrevious revisionNext revision | Previous revisionNext revisionBoth sides next revision | ||
home:othertreatments:antibacterials:highdose [03.06.2011] – external edit 127.0.0.1 | home:othertreatments:antibacterials:highdose [01.03.2012] – external edit 127.0.0.1 | ||
---|---|---|---|
Line 128: | Line 128: | ||
===== Notes and comments ===== | ===== Notes and comments ===== | ||
- | EDIT | + | |
*Legacy content | *Legacy content | ||
* f271 | * f271 | ||
+ | |||
+ | < | ||
+ | |||
+ | topof page | ||
+ | Abstract | ||
+ | |||
+ | Antibiotics have been used effectively as a means to treat bacterial infections in humans and animals for over half a century. However, through their use, lasting alterations are being made to a mutualistic relationship that has taken millennia to evolve: the relationship between the host and its microbiota. Host–microbiota interactions are dynamic; therefore, changes in the microbiota as a consequence of antibiotic treatment can result in the dysregulation of host immune homeostasis and an increased susceptibility to disease. A better understanding of both the changes in the microbiota as a result of antibiotic treatment and the consequential changes in host immune homeostasis is imperative, so that these effects can be mitigated. | ||
+ | </ | ||
===== References ===== | ===== References ===== |